
Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 2296.9
2026-05-21 14:35:45Surging past its previous peaks, Gland Pharma Ltd touched a fresh 52-week high of Rs 2296.9 on 21 May 2026, marking a remarkable 45.5% gain over the past year. This rally stands in stark contrast to the broader Sensex, which has declined by 7.82% over the same period, underscoring the stock's strong momentum amid a challenging market backdrop.
Read More
Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 2295
2026-05-20 09:40:57With a decisive surge to Rs 2295 on 20 May 2026, Gland Pharma Ltd has reached a fresh 52-week high, marking a 50.32% gain over the past year. This rally stands in stark contrast to the Sensex’s 7.72% decline over the same period, underscoring the stock’s strong momentum amid a challenging broader market backdrop.
Read More
Broad-Based Technical Strength Lifts Gland Pharma Ltd to 52-Week High of Rs 2255
2026-05-19 09:41:10Surging to an intraday peak of Rs 2255 on 19 May 2026, Gland Pharma Ltd has marked a fresh 52-week high, extending its impressive rally that has delivered nearly 50% returns over the past year. This milestone comes amid a backdrop of strong technical momentum and a market environment where the broader Sensex trades cautiously below key moving averages.
Read MoreAnnouncement under Regulation 30 (LODR)-Press Release / Media Release
09-Aug-2026 | Source : BSEGland Pharma announces strategic CDMO partnership with a Global Pharmaceutical Company
Announcement under Regulation 30 (LODR)-Press Release / Media Release
05-Aug-2026 | Source : BSEGland Pharma announces strategic collaboration with Neuland Laboratories for sterile API Manufacturing
Announcement under Regulation 30 (LODR)-Newspaper Publication
01-Aug-2026 | Source : BSECopy of News paper Publication
Corporate Actions
No Upcoming Board Meetings
Gland Pharma Ltd has declared 2000% dividend, ex-date: 11 Aug 26
No Splits history available
No Bonus history available
No Rights history available